Literature DB >> 236315

The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH.

M C Lin, Y Salomon, M Rendell, M Rodbell.   

Abstract

The kinetic characteristics of substrate utilization by hepatic adenylate cyclase were investigated under a variety of incubation conditions, including veriations in pH, [substrate], [Mg2+], and in the absence or presence of glucagon. Activities were compared with ATP and 5'-adenylylimidodiphosphate (App(NH)p) as substrates. The Km for both substrates was about 50 muM; Vmax given with App(NH)p was about 40% lower than obtained with ATP as substrate. In the presence of a saturating concentration of substrate (1 mM), basal activity was increased 4-fold by increasing [Mg2+] from 5 to 50 mM. The stimulatory effect of Mg2+ was not due to an allosteric action since basal activity was only marginally enhanced (40%) when the substrate concentration was reduced to 10 muM. As suggested by deHaen ((1974 J. Biol. Chem. 249, 2756), it is likely that Mg2+ increases enzyme activity by decreasing the concentration of an inhibitory, unchelated form of substrate that competes with the productive magnesium-substrate complex at the active site. Activity-pH profiles differed with ATP and App(NH)p as substrates; a shift in pH optimum was observed which correlated with the different pKa of the terminal phosphate groups of ATP and App(nh)p, and which reflect the concentration of protonated substrate (ATPH-3 minus) present in the incubation medium. Accordingly, protonated substrate is the predominant inhibitory species of unchelated substrate and probably has a considerably higher affinity for the active site than does the magnesium-substrate complex. Glucagon-stimulated activity was less susceptible to inhibition by protonated substrate than is the basal state as evidenced by lower stimulatory effect when the [Mg2+] was increased from 5 to 20 mM. However, increasing the [Mg2+] from 20 to 50 mM resulted in marked inhibition of glucagon-stimulated activity, particularly in the presence of 10 muM substrate. Conversely, at a fixed [Mg2+], concentrations of substrate at least 20-fold higher than the Km were required to achieve maximal hormone-stimulated activity. These findings suggest that the unchelated, fully ionized form of substrate serves as an activating ligand, as has been observed with guanine nucleotides at considerably lower concentrations. Thus, Mg2+ affects adenylate cyclase activity by forming the productive substrate complex and by titrating the inhibitory protonated and activating free forms of substrate. As a result of these effects of unchelated substrate, it proved difficult to evaluate the kinetic parameters involved in substrate binding and utilization and the effects of hormone thereon when substrate was added as the only source of activating ligand. However, linear Michaelis kinetic data were obtained by adding the activating ligand 5'-guanylylimidodiphosphate with glucagon and by making appropriate adjustments of pH and [Mg2+]. Vmax was increased 4-fold without changes in Km by the actions of 5'-guanylylimidodiphosphate and glucagon.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236315

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Effects of Mg2+, Mn2+ and Ca2+ on adenylcyclase activity. Evidence for a metallic site.

Authors:  G Wiemer; G Kaiser; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

2.  Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.

Authors:  M E Gnegy; P Uzunov
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

Review 3.  Bistability and control for ATP synthase and adenylate cyclase is obtained by the removal of substrate inhibition.

Authors:  Y Schiffmann
Journal:  Mol Cell Biochem       Date:  1989-03-16       Impact factor: 3.396

4.  Bordetella pertussis adenylate cyclase inactivation by the host cell.

Authors:  A Gilboa-Ron; A Rogel; E Hanski
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

5.  Adenylate cyclase in bloodstream forms of Trypanosoma (Trypanozoon) brucei sp.

Authors:  B R Martin; H P Voorheis; E L Kennedy
Journal:  Biochem J       Date:  1978-10-01       Impact factor: 3.857

6.  Simple model for hormone-activated adenylate cyclase systems.

Authors:  G G Hammes; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

Review 7.  Adenylate cyclase: the role of magnesium and other divalent cations.

Authors:  S Y Cech; W C Broaddus; M E Maguire
Journal:  Mol Cell Biochem       Date:  1980-12-10       Impact factor: 3.396

8.  Comparison of adenylate cyclase activity and in vitro secretion in the parotid and sublingual glands of the mouse.

Authors:  A V Nieuw Amerongen; P A Roukema; A P Vreugdenhil
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

9.  Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms.

Authors:  I A Wadman; R W Farndale; B R Martin
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

10.  Effects of cholera toxin on adenylate cyclase. Studies with guanylylimidodiphosphate.

Authors:  J Flores; G W Sharp
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.